For research use only. Not for therapeutic Use.
Risperidone-d4 is a deuterated form of risperidone, an antipsychotic medication used to treat schizophrenia, bipolar disorder, and irritability associated with autism. In this version, four hydrogen atoms are replaced with deuterium, making it particularly useful in pharmacokinetic and metabolic studies. The deuterium labeling allows for precise tracking and analysis of the drug in the body using mass spectrometry, helping researchers understand its absorption, distribution, metabolism, and excretion. Risperidone-d4 aids in optimizing dosing, reducing side effects, and studying drug interactions.
Catalog Number | R004038 |
CAS Number | 1020719-76-9 |
Synonyms | 3-[2-4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one-d4 |
Molecular Formula | C23H27FN4O2 |
Purity | ≥95% |
Target | Neuronal Signaling |
Storage | Store at -20°C |
IUPAC Name | 2-methyl-3-[1,1,2,2-tetradeuterio-2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one |
InChI | InChI=1S/C23H27FN4O2/c1-15-18(23(29)28-10-3-2-4-21(28)25-15)9-13-27-11-7-16(8-12-27)22-19-6-5-17(24)14-20(19)30-26-22/h5-6,14,16H,2-4,7-13H2,1H3/i9D2,13D2 |
InChIKey | RAPZEAPATHNIPO-RIEWMPPISA-N |
SMILES | CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F |